Free Trial
OTCMKTS:NXNN

Nexeon Medsystems (NXNN) Stock Price, News & Analysis

Nexeon Medsystems logo

About Nexeon Medsystems Stock (OTCMKTS:NXNN)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
200 shs
Average Volume
300 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Receive NXNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexeon Medsystems and its competitors with MarketBeat's FREE daily newsletter.

NXNN Stock News Headlines

Nexeon Medsystems (NXNN) Earnings Dates & Reports
Nexeon MedSystems Inc.
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Nexeon MedSystems Inc (NXNN) Real-Time
Nexeon MedSystems Inc NXNN
See More Headlines

NXNN Stock Analysis - Frequently Asked Questions

Nexeon Medsystems Inc (OTCMKTS:NXNN) released its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.03. The business earned $2.87 million during the quarter, compared to analyst estimates of $1.70 million.

Shares of NXNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nexeon Medsystems investors own include Meta Platforms (META), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Aldeyra Therapeutics (ALDX), Ampliphi Biosciences (APHB), Iovance Biotherapeutics (IOVA) and Myovant Sciences (MYOV).

Company Calendar

Last Earnings
5/21/2018
Today
11/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:NXNN
CIK
N/A
Fax
N/A
Employees
60
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
6.98
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (OTCMKTS:NXNN) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners